Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in surgical pathology Mesothelioma / / Richard L. Attanoos, Timothy Craig Allen
| Advances in surgical pathology Mesothelioma / / Richard L. Attanoos, Timothy Craig Allen |
| Autore | Attanoos Richard L |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer Health / Lippincott Williams & Wilkins, , [2014] |
| Descrizione fisica | 1 online resource (xiv, 188 pages) : illustrations (chiefly color) |
| Disciplina | 616.99/424 |
| Collana |
Advances in surgical pathology series
Gale eBooks |
| Soggetto topico |
Mesothelioma
Cancer - Pathophysiology Cancer - Treatment Cancer - Surgery Pathology, Surgical |
| ISBN |
1-4511-5384-8
1-4698-7988-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | section I. Epidemiologic, clinical, and radiologic features -- section II. Histopathology -- section III. Molecular features. |
| Record Nr. | UNINA-9910789130403321 |
Attanoos Richard L
|
||
| Philadelphia : , : Wolters Kluwer Health / Lippincott Williams & Wilkins, , [2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in surgical pathology Mesothelioma / / Richard L. Attanoos, Timothy Craig Allen
| Advances in surgical pathology Mesothelioma / / Richard L. Attanoos, Timothy Craig Allen |
| Autore | Attanoos Richard L |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer Health / Lippincott Williams & Wilkins, , [2014] |
| Descrizione fisica | 1 online resource (xiv, 188 pages) : illustrations (chiefly color) |
| Disciplina | 616.99/424 |
| Collana |
Advances in surgical pathology series
Gale eBooks |
| Soggetto topico |
Mesothelioma
Cancer - Pathophysiology Cancer - Treatment Cancer - Surgery Pathology, Surgical |
| ISBN |
1-4511-5384-8
1-4698-7988-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | section I. Epidemiologic, clinical, and radiologic features -- section II. Histopathology -- section III. Molecular features. |
| Record Nr. | UNINA-9910828145803321 |
|
Attanoos Richard L
|
||
| Philadelphia : , : Wolters Kluwer Health / Lippincott Williams & Wilkins, , [2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer symptom science : measurement, mechanisms, and management / / edited by Charles S. Cleeland, Michael J. Fisch [and] Adrian Dunn [[electronic resource]]
| Cancer symptom science : measurement, mechanisms, and management / / edited by Charles S. Cleeland, Michael J. Fisch [and] Adrian Dunn [[electronic resource]] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2011 |
| Descrizione fisica | 1 online resource (xvii, 356 pages) : digital, PDF file(s) |
| Disciplina | 616.99/4071 |
| Collana | Cambridge medicine Cancer symptom science |
| Soggetto topico |
Cancer - Pathophysiology
Symptoms |
| ISBN |
1-107-21867-5
0-511-85175-8 1-282-91852-4 9786612918520 0-511-91806-2 0-511-78086-9 0-511-91527-6 0-511-91904-2 0-511-91348-6 0-511-91708-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: Preface; Foreword; Part I. Introduction: 1. Introduction to Cancer Symptom Science Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; 2. Researching the mechanisms underlying the symptoms of patients with cancer Adrian J. Dunn; 3. Cytokines, sickness behavior: a model for cancer symptoms Steven S. Zalcman, Randall T. Woodruff, Ruchika Mohla and Allan Siegal; Part II. Cancer Symptom Mechanisms and Models: Clinical and Basic Science: 4. The clinical science of cancer pain assessment and management Russell K. Portenoy and Victor T. Chang; 5. Pain: basic science: 5a. Mechanisms of disease-related pain in cancer: insights from the study of bone tumors Patrick W. Mantyh and Juan Miguel Jimenez Andrade; 5b. Neuropathic pain: basic science Patrick M. Dougherty and Haijun Zhang; 6. Cognitive dysfunction: is chemobrain real? Christina A. Meyers and Jeffrey S. Wefel; 7. Cognitive impairment: basic science Perry N. Fuchs, Jessica A. Boyette-Davis and Adrian J. Dunn; 8. Depression in cancer: pathophysiology at the mind-body interface Andrew H. Miller, Michael A. Burke and Charles L. Raison; 9. Depressive illness: basic science: 9a. Animal models of depressed mood and sickness behavior Adrian J. Dunn; 9b. From inflammation to sickness and depression: the cytokine connection Robert Dantzer and Keith W. Kelly; 10. Cancer-related fatigue: clinical science Xin Shelley Wang; 11. Developing translational animal models of cancer-related fatigue Mary W. Meagher; 12. Cancer anorexia/weight loss syndrome Aminah Jatoi and Nisha Lassi; 13. Appetite loss/cachexia: basic science Tristin D. Brisbois-Clarkson, Wendy V. Wismer and Vickie E. Baracos; 14. Sleep and its disorders: clinical science Sofia Ancoli-Israel and Lianqi Liu; 15. Sleep and its disorders Mark R. Opp and Luca Imeri; 16. Proteins and symptoms Bang-Ning Lee and James M. Reuben; 17. Genetic approaches to treating and preventing symptoms in patients with cancer Quiling Shi and Charles S. Cleeland; 18. Functional imaging of symptoms T. Dorina Papageorgiou, Edward F. Jackson and Javier O. Valenzuela; 19. High-dose therapy and posttransplantation symptom burden: striking a balance Sergio A. Giralt and Loretta A. Williams; Part III. Clinical Perspectives in Symptom Management and Research: 20. Promoting symptom research in cooperative groups Lynne I. Wagner and David Cella; 21. Practical aspects of symptom management in patients with cancer Richard T. Lee and Michael J. Fisch; Part IV. Symptom Measurement: 22. Symptom measurement by patient report Charles S. Cleeland and Tito R. Mendoza; 23. The economics of cancer-related symptoms: valuing supportive care interventions Lesley-Ann Miller and Jane C. Weeks; 24. Longitudinal models for symptoms Diane L. Fairclough; 25. Bayesian adaptive design: a new approach to test the effectiveness of symptom-reducing agents using patient-reported outcomes Valen E. Johnson and Tito R. Mendoza; Part V. Government and Industry Perspectives: 26. Promoting cancer symptom science research Ann O'Mara and Maria Sgambati; 27. Developing symptom management drugs Joanna M. Brell and Lori M. Minasian; 28. Cancer-related symptoms: issues for consideration in drug and therapeutic biological product label claims in the United States Jane A. Scott; 29. Symptom research: looking ahead Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; Index. |
| Record Nr. | UNINA-9910459096203321 |
| Cambridge : , : Cambridge University Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer symptom science : measurement, mechanisms, and management / / edited by Charles S. Cleeland, Michael J. Fisch [and] Adrian Dunn [[electronic resource]]
| Cancer symptom science : measurement, mechanisms, and management / / edited by Charles S. Cleeland, Michael J. Fisch [and] Adrian Dunn [[electronic resource]] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2011 |
| Descrizione fisica | 1 online resource (xvii, 356 pages) : digital, PDF file(s) |
| Disciplina | 616.99/4071 |
| Collana | Cambridge medicine Cancer symptom science |
| Soggetto topico |
Cancer - Pathophysiology
Symptoms |
| ISBN |
1-107-21867-5
0-511-85175-8 1-282-91852-4 9786612918520 0-511-91806-2 0-511-78086-9 0-511-91527-6 0-511-91904-2 0-511-91348-6 0-511-91708-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: Preface; Foreword; Part I. Introduction: 1. Introduction to Cancer Symptom Science Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; 2. Researching the mechanisms underlying the symptoms of patients with cancer Adrian J. Dunn; 3. Cytokines, sickness behavior: a model for cancer symptoms Steven S. Zalcman, Randall T. Woodruff, Ruchika Mohla and Allan Siegal; Part II. Cancer Symptom Mechanisms and Models: Clinical and Basic Science: 4. The clinical science of cancer pain assessment and management Russell K. Portenoy and Victor T. Chang; 5. Pain: basic science: 5a. Mechanisms of disease-related pain in cancer: insights from the study of bone tumors Patrick W. Mantyh and Juan Miguel Jimenez Andrade; 5b. Neuropathic pain: basic science Patrick M. Dougherty and Haijun Zhang; 6. Cognitive dysfunction: is chemobrain real? Christina A. Meyers and Jeffrey S. Wefel; 7. Cognitive impairment: basic science Perry N. Fuchs, Jessica A. Boyette-Davis and Adrian J. Dunn; 8. Depression in cancer: pathophysiology at the mind-body interface Andrew H. Miller, Michael A. Burke and Charles L. Raison; 9. Depressive illness: basic science: 9a. Animal models of depressed mood and sickness behavior Adrian J. Dunn; 9b. From inflammation to sickness and depression: the cytokine connection Robert Dantzer and Keith W. Kelly; 10. Cancer-related fatigue: clinical science Xin Shelley Wang; 11. Developing translational animal models of cancer-related fatigue Mary W. Meagher; 12. Cancer anorexia/weight loss syndrome Aminah Jatoi and Nisha Lassi; 13. Appetite loss/cachexia: basic science Tristin D. Brisbois-Clarkson, Wendy V. Wismer and Vickie E. Baracos; 14. Sleep and its disorders: clinical science Sofia Ancoli-Israel and Lianqi Liu; 15. Sleep and its disorders Mark R. Opp and Luca Imeri; 16. Proteins and symptoms Bang-Ning Lee and James M. Reuben; 17. Genetic approaches to treating and preventing symptoms in patients with cancer Quiling Shi and Charles S. Cleeland; 18. Functional imaging of symptoms T. Dorina Papageorgiou, Edward F. Jackson and Javier O. Valenzuela; 19. High-dose therapy and posttransplantation symptom burden: striking a balance Sergio A. Giralt and Loretta A. Williams; Part III. Clinical Perspectives in Symptom Management and Research: 20. Promoting symptom research in cooperative groups Lynne I. Wagner and David Cella; 21. Practical aspects of symptom management in patients with cancer Richard T. Lee and Michael J. Fisch; Part IV. Symptom Measurement: 22. Symptom measurement by patient report Charles S. Cleeland and Tito R. Mendoza; 23. The economics of cancer-related symptoms: valuing supportive care interventions Lesley-Ann Miller and Jane C. Weeks; 24. Longitudinal models for symptoms Diane L. Fairclough; 25. Bayesian adaptive design: a new approach to test the effectiveness of symptom-reducing agents using patient-reported outcomes Valen E. Johnson and Tito R. Mendoza; Part V. Government and Industry Perspectives: 26. Promoting cancer symptom science research Ann O'Mara and Maria Sgambati; 27. Developing symptom management drugs Joanna M. Brell and Lori M. Minasian; 28. Cancer-related symptoms: issues for consideration in drug and therapeutic biological product label claims in the United States Jane A. Scott; 29. Symptom research: looking ahead Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; Index. |
| Record Nr. | UNINA-9910785495303321 |
| Cambridge : , : Cambridge University Press, , 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer symptom science : measurement, mechanisms, and management / / edited by Charles S. Cleeland, Michael J. Fisch, Adrian Dunn
| Cancer symptom science : measurement, mechanisms, and management / / edited by Charles S. Cleeland, Michael J. Fisch, Adrian Dunn |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Cambridge ; ; New York, : Cambridge University Press, 2010 |
| Descrizione fisica | 1 online resource (xvii, 356 pages) : digital, PDF file(s) |
| Disciplina | 616.99/4071 |
| Altri autori (Persone) |
CleelandCharles S
DunnAdrian J FischMichael J. <1964-> |
| Collana | Cambridge medicine Cancer symptom science |
| Soggetto topico |
Cancer - Pathophysiology
Symptoms |
| ISBN |
1-107-21867-5
0-511-85175-8 1-282-91852-4 9786612918520 0-511-91806-2 0-511-78086-9 0-511-91527-6 0-511-91904-2 0-511-91348-6 0-511-91708-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Machine generated contents note: Preface; Foreword; Part I. Introduction: 1. Introduction to Cancer Symptom Science Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; 2. Researching the mechanisms underlying the symptoms of patients with cancer Adrian J. Dunn; 3. Cytokines, sickness behavior: a model for cancer symptoms Steven S. Zalcman, Randall T. Woodruff, Ruchika Mohla and Allan Siegal; Part II. Cancer Symptom Mechanisms and Models: Clinical and Basic Science: 4. The clinical science of cancer pain assessment and management Russell K. Portenoy and Victor T. Chang; 5. Pain: basic science: 5a. Mechanisms of disease-related pain in cancer: insights from the study of bone tumors Patrick W. Mantyh and Juan Miguel Jimenez Andrade; 5b. Neuropathic pain: basic science Patrick M. Dougherty and Haijun Zhang; 6. Cognitive dysfunction: is chemobrain real? Christina A. Meyers and Jeffrey S. Wefel; 7. Cognitive impairment: basic science Perry N. Fuchs, Jessica A. Boyette-Davis and Adrian J. Dunn; 8. Depression in cancer: pathophysiology at the mind-body interface Andrew H. Miller, Michael A. Burke and Charles L. Raison; 9. Depressive illness: basic science: 9a. Animal models of depressed mood and sickness behavior Adrian J. Dunn; 9b. From inflammation to sickness and depression: the cytokine connection Robert Dantzer and Keith W. Kelly; 10. Cancer-related fatigue: clinical science Xin Shelley Wang; 11. Developing translational animal models of cancer-related fatigue Mary W. Meagher; 12. Cancer anorexia/weight loss syndrome Aminah Jatoi and Nisha Lassi; 13. Appetite loss/cachexia: basic science Tristin D. Brisbois-Clarkson, Wendy V. Wismer and Vickie E. Baracos; 14. Sleep and its disorders: clinical science Sofia Ancoli-Israel and Lianqi Liu; 15. Sleep and its disorders Mark R. Opp and Luca Imeri; 16. Proteins and symptoms Bang-Ning Lee and James M. Reuben; 17. Genetic approaches to treating and preventing symptoms in patients with cancer Quiling Shi and Charles S. Cleeland; 18. Functional imaging of symptoms T. Dorina Papageorgiou, Edward F. Jackson and Javier O. Valenzuela; 19. High-dose therapy and posttransplantation symptom burden: striking a balance Sergio A. Giralt and Loretta A. Williams; Part III. Clinical Perspectives in Symptom Management and Research: 20. Promoting symptom research in cooperative groups Lynne I. Wagner and David Cella; 21. Practical aspects of symptom management in patients with cancer Richard T. Lee and Michael J. Fisch; Part IV. Symptom Measurement: 22. Symptom measurement by patient report Charles S. Cleeland and Tito R. Mendoza; 23. The economics of cancer-related symptoms: valuing supportive care interventions Lesley-Ann Miller and Jane C. Weeks; 24. Longitudinal models for symptoms Diane L. Fairclough; 25. Bayesian adaptive design: a new approach to test the effectiveness of symptom-reducing agents using patient-reported outcomes Valen E. Johnson and Tito R. Mendoza; Part V. Government and Industry Perspectives: 26. Promoting cancer symptom science research Ann O'Mara and Maria Sgambati; 27. Developing symptom management drugs Joanna M. Brell and Lori M. Minasian; 28. Cancer-related symptoms: issues for consideration in drug and therapeutic biological product label claims in the United States Jane A. Scott; 29. Symptom research: looking ahead Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; Index. |
| Record Nr. | UNINA-9910815461503321 |
| Cambridge ; ; New York, : Cambridge University Press, 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Handbook of oxidative stress in cancer : therapeutic aspects / / edited by Sajal Chakraborti
| Handbook of oxidative stress in cancer : therapeutic aspects / / edited by Sajal Chakraborti |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (4076 pages) |
| Disciplina | 610.73 |
| Soggetto topico |
Cancer - Treatment
Cancer - Pathophysiology Oxidative stress |
| ISBN |
9789811654220
9789811654213 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- About the Editor -- Contributors -- Part I: Therapeutic Implications of Natural Compounds -- 1 Elimination of Senescent Cells by Polyphenols and Flavonoids -- Introduction -- Cellular Senescence -- Markers of Cellular Senescence -- Senescence-Associated Mitochondrial Dysfunction (SAMD) -- Senescence-Associated Secretory Phenotype (SASP) -- Bystander Effect -- Therapy-Induced Senescence (TIS) -- TIS Induced by Polyphenols -- Escape From TIS -- Senescent Cells: A Survival Niche Generating a Complex Tumor Environment -- Importance of TIS by the Example of Radiotherapy-Induced Senescence -- Role of TIS in Other Cancer Treatments -- Polyphenols Inhibiting SASP (Senostatics) -- Apigenin -- Epigallocatechin-3-Gallate (EGCG) -- Resveratrol -- Quercetin -- Polyphenols as Senolytics (Polyphenols Killing Senescent Cells) -- Fisetin -- Quercetin -- Epigallocatechin-3-Gallate (EGCG) -- Curcumin -- Herbal Extracts with Senolytic and Senomorphic Properties -- Extract of the Plant Solidago virgaurea Subsp. alpestris -- Alcoholic Extract of Ajuga taiwanensis -- Pinellia ternata Tuber -- Olive Plant -- Conclusion -- References -- 2 Natural Dietary Alkaloids and Its Synthetic Derivatives as Oxidative Stress-Inducing Agents for Cancer Therapy -- Introduction -- Berberine -- Piperine -- Neferine -- Piperlongumine -- Conclusion -- References -- 3 Natural Therapeutic Strategies for Modulating Oxidative Stress in Cancer -- Introduction -- Oxidative Stress and Carcinogenesis -- Antioxidant Defense Mechanism -- Oxidative Stress and Natural Compounds -- The Role of Antioxidant Potential of Phytochemicals in Oxidative Stress -- Mechanism of Natural Compounds in Combination with Chemotherapy -- Marine Product with Antioxidative Stress Activity -- Microbial Antioxidative Stress Compounds -- Conclusion -- Future Perspective -- References.
4 Antioxidant in Cancer -- Introduction -- Reactive Oxygen Species (ROS) -- Reactive Oxygen Species (ROS) in Cancer -- Antioxidants -- Antioxidants Types -- Defense Mechanism of Antioxidant -- Antioxidant: Preventer of Cancer -- Antioxidant: Promoter of Cancer -- Antioxidant: An Achilles´ Heel -- The Antioxidant Conundrum: Friend or Foe -- Conclusion -- References -- 5 Antioxidant Activity of Phytochemicals in Cancer -- Introduction -- Role of Reactive Oxygen Species (ROS) in Cancer Progression -- ROS and Chemoresistance Development -- Cellular Redox System and Molecular Mechanisms Against ROS -- Phytochemicals and Their Antioxidant Activity in Cancer -- Triphala -- Resveratrol -- Indole-3 Carbinol (I3C) -- Peucedanum Chenur -- Astaxanthin -- Quercetin -- Ellagic Acid -- Caryophyllene Sesquiterpenes -- Phlorotannins -- The Antioxidant/Pro-oxidant Enigma of Cancer Therapy -- Phytochemicals as Immunotherapy Adjuvants -- Conclusion and Future Perspectives -- References -- 6 Therapeutic Application of Microbial Metabolites in Free Radical-Induced Tumorigenesis -- Introduction -- Role of ROS in Tumorigenesis -- Antioxidant Compounds from Microbial Sources -- Role of Secondary Metabolites of Actinobacteria in Anticancer Activity -- Role of Exopolysaccharides of Lactic Acid Bacteria in Anticancer Activity -- Effect of Bacterial Toxins and Enzymes on Anti-tumorigenesis -- Role of Biosurfactants from Microorganisms in Antitumor Therapy -- Conclusion and Future Perspectives -- References -- 7 Therapeutic Potential of Natural Agents Against Oxidative Stress-Influenced Colitis-Associated Cancer -- Introduction -- Colitis-Associated Cancer (CAC) -- Sources of Free Radicals in the Colon -- Food -- Obesity -- Age -- Reactive Oxygen Species (ROS) -- Role of ROS in CAC -- Natural Agents and Its Mechanism of Action on CAC -- Mechanism of Action of Procyanidin B on CAC. Mechanism of Action of Shaoyao Decoction on CAC -- Mechanism of Action of Red Ginseng Oil on CAC -- Mechanism of Action of Caffeic Acid Phenethyl Ester on CAC -- Mechanism of Action of Lyophilized Acai Pulp on CAC -- Protocatechuic Acid on CAC -- Betaine on CAC -- Sasa quelpaertensis Leaf Extract on CAC -- Oligonol on CAC -- Embelin on CAC -- Phytosomal Curcumin on CAC -- Rutaecarpine on CAC -- Vanillin on CAC -- Huangqin Decoction on CAC -- American Ginseng on CAC -- Hydroxychloroquine on CAC -- Conclusion -- Future Directions -- References -- 8 Oxidative Stress: A Double Edged Sword in Cancer -- Introduction -- Tetrandrine as ROS Scavenger -- Tetrandrine-Induced ROS-Mediated Autophagy -- Tetrandrine-Induced ROS-Mediated Apoptosis -- Conclusion -- References -- 9 Prevention of Fertility due to Chemotherapy-Induced Ovarian Failure: Role of Therapeutic Antioxidants -- Introduction -- Types of Cytotoxic Drugs -- Pathways of Chemotherapy-Induced Ovarian Damage -- Chemotherapy-Induced Oxidative Stress -- Cellular Background of Oxidative Stress -- Redox State and Oxidative Stress -- Antioxidant System and Use of Antioxidants During Chemotherapy -- Adjuvant Antioxidants -- Vitamin C and Vitamin E -- Melatonin -- Other Antioxidants -- Conclusion and Future Perspective -- References -- 10 Therapeutic Implications of Phytochemicals in ROS-Induced Cancer -- Introduction -- Reactive Oxygen Species in Cancer -- Carcinogenesis and Phytochemicals -- Chemoprevention: Types and Approaches -- Dietary Phytochemicals: Role in Cancer Chemoprevention -- Phytochemicals: Polyphenols -- Flavonoids -- Apigenin -- Isoflavonoids -- Anthocyanidins -- Phytoestrogens -- Resveratrol -- Curcumin -- Terpenoids -- Carotenoids -- Lycopene -- Limonoids -- Glucosinolates -- α-Linolenic Acid (ALA) -- Allicin -- Silymarin -- Sulforaphane (SFN) -- Conclusions -- References. 11 Nutraceuticals in Cancer Therapy -- Introduction -- Nutraceuticals and Cancer -- Flavonoids and Polyphenols -- Catechins -- Theaflavins and Thearubigins -- Flavonoids -- Non-flavonoidal Anti-cancer Nutraceuticals -- Organosulfur Compounds -- Sulforaphane (SLFN) -- Glucobrassicin and Indole-3-Carbinol -- Diallyl-Disulfide and Thiosulfinates -- Carotenoids -- Resveratrol -- Curcumin -- Cancer and Diet -- Molecular Biology Effects -- Effect of Nutritional Support on Cancer Patients -- Nutraceuticals: Challenges and Perspectives -- Conclusion -- References -- 12 Potential Natural Product-Derived Compounds for Lung Cancer Therapy -- Lung Cancer -- Types and Staging of Lung Cancer -- Lung Cancer and Oxidative Stress Potential Sources -- Oxidative Stress and Biological Effects -- Apoptotic Cell Death and Oxidative Stress -- Apoptosis -- Potentials Targets of Drug Action in Relevance to Reactive Oxygen Species and Redox Regulation -- Misfolded Proteins, Reactive Oxygen Species (ROS), and the Endoplasmic Reticulum Stress (ER Stress) -- ER Stress as a Target for Lung Cancer Treatment -- CSC and Oxidative Stress in Lung Cancer -- Natural Product Derived Compounds -- New Anticancer Compounds from Plants -- Gallic Acid -- Curcumin -- Flavonoids -- Green Tea Polyphenols -- Genistein -- Tangeretin -- Resveratrol -- Lectins -- Natural Product-Derived Compound Regulating Mitochondrial Pathway -- Gracillin -- Quercetin -- Resveratrol -- Pterostilbene -- Honokiol -- Betulinic Acid -- Marine-Derived Compounds for Cancer Treatment -- Ecteinascidin Alkaloids -- Psammaplin A -- Didemnin B -- Dolastatin 10 -- Halichondrin B -- References -- 13 Role of Dietary Antioxidants in Chemoprevention of Nitrosamines-Induced Carcinogenesis -- Introduction -- Causes of Chemical Carcinogenesis -- Carcinogenicity of N-nitroso Compounds -- Dietary Cancer Prevention -- Chemoprevention. Dietary Intervention -- Lycopene -- Vitamins -- Carotenoids -- Isothiocyanates -- Polyphenols -- Flavonoids -- Calcium -- Astaxanthin -- Conclusion -- Future Direction -- References -- 14 Natural Antioxidants for the Prevention and Treatment of Cancer -- Introduction -- Free Radicals, Oxidative Processes, and Cell Changes -- Secondary Metabolites, Sources, and Nutritional Implications -- Herbal Bioactive Compounds and their Molecular Targets -- Benefits and Risks of Concomitant Use of Secondary Metabolites and Cytotoxic Drugs -- Novel Uses of Secondary Metabolites in Cancer Research -- Conclusions and Future Directions -- References -- 15 Protective Effect of Quercetin, Luteolin, and Fisetin via Stimulating the p53-Mediated Signaling in Cancer -- Introduction -- Structure of p53 -- Regulation of p53 Level and Activity -- Physiological Functions of p53 -- Cell Cycle Regulation -- Induction of Apoptosis -- p53 in Response to DNA Damage -- p53 Targets Survival Signaling -- p53 and Its Cross Talk with Other Signaling Pathways -- p53 and Its Cross Talk with NF-κB -- p53 and Oxidative Stress -- Conclusion -- Future Perspective -- References -- 16 Flavonoids and Its Anticancer Activity for ROS-Induced Breast Cancer -- Introduction -- ROS Level and Cellular Homeostasis -- ROS in Cancer Signaling Pathway -- Flavonoids as Anticancer Agents -- Chemistry and Classification -- Absorption, Metabolism, and Bioavailability of Flavonoids -- Anticancer Effects of Flavonoid -- Effect of Flavonoids on Breast Cancer -- Molecular Mechanism of Action -- Flavonoids for Breast Cancer -- Conclusion -- References -- 17 Role of Indian Ginseng Withaferin A in ROS-Induced Cancer Chemoprevention and Cancer Therapy -- Introduction -- Plant Distribution and Phylogeny -- Chemical Constituents of Ashwagandha Roots -- Pharmacological Effects of Withania somnifera. Anti-inflammatory Properties. |
| Record Nr. | UNINA-9910616378603321 |
| Gateway East, Singapore : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The neuropsychology of cancer and oncology / / editors, Chad A. Noggle & Raymond S. Dean
| The neuropsychology of cancer and oncology / / editors, Chad A. Noggle & Raymond S. Dean |
| Pubbl/distr/stampa | New York : , : Springer Pub., , [2013] |
| Descrizione fisica | 1 online resource (488 p.) |
| Disciplina | 616.99/4 |
| Altri autori (Persone) |
NoggleChad A
DeanRaymond S |
| Collana | Contemporary neuropsychology series |
| Soggetto topico |
Cancer - Pathophysiology
Neuropsychology |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-8261-0694-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; About the Editors; About the Associate Editors; Title; Copyright; Contents; Contributors; Preface; Acknowledgments; Series Editors; Section I: Biological Components, Medical Care, and Special Considerations; Chapter 1: Neuropsychology and Cancer: An Emerging Focus; History of Neuropsychology; Neuropsychological Practice; Neuropsychological Practice in Oncology; Neuropsychological Impact of Cancer and Oncology; Disease-Related Deficits; Treatment-Related Deficits; Pharmacological Effects; Summary; References; Chapter 2: Urological Cancers; Bladder Cancer
Presentation, Diagnosis, and Staging in Bladder CancerTreatment Approaches and Functional Outcomes in Bladder Cancer; Kidney Cancer: Presentation, Diagnosis, and Staging in Kidney Cancer; Treatment Approaches and Functional Outcomes in Kidney Cancer; Prostate Cancer: Presentation, Diagnosis, and Staging in Prostate Cancer; Treatment Approaches and Functional Outcomes in Prostate Cancer; Testicular Cancer: Presentation, Diagnosis, and Staging in Testicular Cancer; Treatment Approaches and Functional Outcomes in Testicular Cancer; Neuropsychological Residuals in Urological Cancers Brain MetastasesNeurological and Neuropsychological Sequelae; Summary; References; Chapter 3: Neuropsychological Sequelae of Breast Cancer and Its Treatment; Background: Biology, Clinical Presentation, and Treatment of Breast Cancer: Epidemiology; Symptoms and Diagnostic Workup; Prognosis by Stage; Surgical Management of Breast Cancer; Treatment of Brain and Spinal Metastases; Potential Neurophysiological Alterations After Breast Cancer Therapy; Peripheral Neuropathies; Central Nervous System Effects; Summary; References Chapter 4: Neurocognitive Impact of Gynecologic Cancers and Their TreatmentPart I: Gynecologic Cancers: Types, Epidemiology, and Current Practices for Gynecologic Cancers; Empirically Based Treatment Considerations; Part II: Potential Neurophysiologic Alterations; Research in Gynecologic Cancer; Summary; References; Chapter 5: Colorectal Cancers; Management of Colorectal Cancer; Surgery; Chemotherapy; Pelvic Radiotherapy; Functional Outcomes After Treatment of Colorectal Cancer; Permanent Colostomy; Bowel Function; Cognitive Function; Impact of Cognitive Dysfunction on Quality of Life Cancer-Related Cognitive DysfunctionTreatment-Related Cognitive Function; Postoperative Cognitive Function; Postoperative Delerium; Chemotherapy for Colorectal Cancer; Chemotherapy-Related Cognitive Dysfunction; Mechanism of Chemotherapy-Related Cognitive Dysfunction; 5-Flourouracil; Oxaliplatin; Capecitabine; Biologic Agents; Adjuvant Medications; Methodological Issues in Assessing Cognitive Dysfunction After Colorectal Cancer Treatment; Choice of Instruments; Statistical Analysis; Management of Cognitive Dysfunction; Summary; References Chapter 6: The Neuropsychological Aspects of Head and Neck Cancer |
| Record Nr. | UNINA-9910463023203321 |
| New York : , : Springer Pub., , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The neuropsychology of cancer and oncology / / editors, Chad A. Noggle & Raymond S. Dean
| The neuropsychology of cancer and oncology / / editors, Chad A. Noggle & Raymond S. Dean |
| Pubbl/distr/stampa | New York : , : Springer Pub., , [2013] |
| Descrizione fisica | 1 online resource (488 p.) |
| Disciplina | 616.99/4 |
| Altri autori (Persone) |
NoggleChad A
DeanRaymond S |
| Collana | Contemporary neuropsychology series |
| Soggetto topico |
Cancer - Pathophysiology
Neuropsychology |
| ISBN | 0-8261-0694-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; About the Editors; About the Associate Editors; Title; Copyright; Contents; Contributors; Preface; Acknowledgments; Series Editors; Section I: Biological Components, Medical Care, and Special Considerations; Chapter 1: Neuropsychology and Cancer: An Emerging Focus; History of Neuropsychology; Neuropsychological Practice; Neuropsychological Practice in Oncology; Neuropsychological Impact of Cancer and Oncology; Disease-Related Deficits; Treatment-Related Deficits; Pharmacological Effects; Summary; References; Chapter 2: Urological Cancers; Bladder Cancer
Presentation, Diagnosis, and Staging in Bladder CancerTreatment Approaches and Functional Outcomes in Bladder Cancer; Kidney Cancer: Presentation, Diagnosis, and Staging in Kidney Cancer; Treatment Approaches and Functional Outcomes in Kidney Cancer; Prostate Cancer: Presentation, Diagnosis, and Staging in Prostate Cancer; Treatment Approaches and Functional Outcomes in Prostate Cancer; Testicular Cancer: Presentation, Diagnosis, and Staging in Testicular Cancer; Treatment Approaches and Functional Outcomes in Testicular Cancer; Neuropsychological Residuals in Urological Cancers Brain MetastasesNeurological and Neuropsychological Sequelae; Summary; References; Chapter 3: Neuropsychological Sequelae of Breast Cancer and Its Treatment; Background: Biology, Clinical Presentation, and Treatment of Breast Cancer: Epidemiology; Symptoms and Diagnostic Workup; Prognosis by Stage; Surgical Management of Breast Cancer; Treatment of Brain and Spinal Metastases; Potential Neurophysiological Alterations After Breast Cancer Therapy; Peripheral Neuropathies; Central Nervous System Effects; Summary; References Chapter 4: Neurocognitive Impact of Gynecologic Cancers and Their TreatmentPart I: Gynecologic Cancers: Types, Epidemiology, and Current Practices for Gynecologic Cancers; Empirically Based Treatment Considerations; Part II: Potential Neurophysiologic Alterations; Research in Gynecologic Cancer; Summary; References; Chapter 5: Colorectal Cancers; Management of Colorectal Cancer; Surgery; Chemotherapy; Pelvic Radiotherapy; Functional Outcomes After Treatment of Colorectal Cancer; Permanent Colostomy; Bowel Function; Cognitive Function; Impact of Cognitive Dysfunction on Quality of Life Cancer-Related Cognitive DysfunctionTreatment-Related Cognitive Function; Postoperative Cognitive Function; Postoperative Delerium; Chemotherapy for Colorectal Cancer; Chemotherapy-Related Cognitive Dysfunction; Mechanism of Chemotherapy-Related Cognitive Dysfunction; 5-Flourouracil; Oxaliplatin; Capecitabine; Biologic Agents; Adjuvant Medications; Methodological Issues in Assessing Cognitive Dysfunction After Colorectal Cancer Treatment; Choice of Instruments; Statistical Analysis; Management of Cognitive Dysfunction; Summary; References Chapter 6: The Neuropsychological Aspects of Head and Neck Cancer |
| Record Nr. | UNINA-9910786144003321 |
| New York : , : Springer Pub., , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The neuropsychology of cancer and oncology / / editors, Chad A. Noggle & Raymond S. Dean
| The neuropsychology of cancer and oncology / / editors, Chad A. Noggle & Raymond S. Dean |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | New York : , : Springer Pub., , [2013] |
| Descrizione fisica | 1 online resource (488 p.) |
| Disciplina |
616.99/4
616.99407 |
| Altri autori (Persone) |
NoggleChad A
DeanRaymond S |
| Collana | Contemporary neuropsychology series |
| Soggetto topico |
Cancer - Pathophysiology
Neuropsychology |
| ISBN | 0-8261-0694-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; About the Editors; About the Associate Editors; Title; Copyright; Contents; Contributors; Preface; Acknowledgments; Series Editors; Section I: Biological Components, Medical Care, and Special Considerations; Chapter 1: Neuropsychology and Cancer: An Emerging Focus; History of Neuropsychology; Neuropsychological Practice; Neuropsychological Practice in Oncology; Neuropsychological Impact of Cancer and Oncology; Disease-Related Deficits; Treatment-Related Deficits; Pharmacological Effects; Summary; References; Chapter 2: Urological Cancers; Bladder Cancer
Presentation, Diagnosis, and Staging in Bladder CancerTreatment Approaches and Functional Outcomes in Bladder Cancer; Kidney Cancer: Presentation, Diagnosis, and Staging in Kidney Cancer; Treatment Approaches and Functional Outcomes in Kidney Cancer; Prostate Cancer: Presentation, Diagnosis, and Staging in Prostate Cancer; Treatment Approaches and Functional Outcomes in Prostate Cancer; Testicular Cancer: Presentation, Diagnosis, and Staging in Testicular Cancer; Treatment Approaches and Functional Outcomes in Testicular Cancer; Neuropsychological Residuals in Urological Cancers Brain MetastasesNeurological and Neuropsychological Sequelae; Summary; References; Chapter 3: Neuropsychological Sequelae of Breast Cancer and Its Treatment; Background: Biology, Clinical Presentation, and Treatment of Breast Cancer: Epidemiology; Symptoms and Diagnostic Workup; Prognosis by Stage; Surgical Management of Breast Cancer; Treatment of Brain and Spinal Metastases; Potential Neurophysiological Alterations After Breast Cancer Therapy; Peripheral Neuropathies; Central Nervous System Effects; Summary; References Chapter 4: Neurocognitive Impact of Gynecologic Cancers and Their TreatmentPart I: Gynecologic Cancers: Types, Epidemiology, and Current Practices for Gynecologic Cancers; Empirically Based Treatment Considerations; Part II: Potential Neurophysiologic Alterations; Research in Gynecologic Cancer; Summary; References; Chapter 5: Colorectal Cancers; Management of Colorectal Cancer; Surgery; Chemotherapy; Pelvic Radiotherapy; Functional Outcomes After Treatment of Colorectal Cancer; Permanent Colostomy; Bowel Function; Cognitive Function; Impact of Cognitive Dysfunction on Quality of Life Cancer-Related Cognitive DysfunctionTreatment-Related Cognitive Function; Postoperative Cognitive Function; Postoperative Delerium; Chemotherapy for Colorectal Cancer; Chemotherapy-Related Cognitive Dysfunction; Mechanism of Chemotherapy-Related Cognitive Dysfunction; 5-Flourouracil; Oxaliplatin; Capecitabine; Biologic Agents; Adjuvant Medications; Methodological Issues in Assessing Cognitive Dysfunction After Colorectal Cancer Treatment; Choice of Instruments; Statistical Analysis; Management of Cognitive Dysfunction; Summary; References Chapter 6: The Neuropsychological Aspects of Head and Neck Cancer |
| Record Nr. | UNINA-9910813771103321 |
| New York : , : Springer Pub., , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Reduction of sporadic malignancies by stimulation of cellular repair systems and by targeting cellular energy metabolism / / Borut Poljsak [and four others]
| Reduction of sporadic malignancies by stimulation of cellular repair systems and by targeting cellular energy metabolism / / Borut Poljsak [and four others] |
| Autore | Poljsak Borut |
| Pubbl/distr/stampa | Hauppauge, NY : , : Nova Science Publishers, Incorporated, , [2017] |
| Descrizione fisica | 1 online resource (96 pages) : illustrations |
| Disciplina | 616.99/4061 |
| Collana | Cancer etiology, diagnosis and treatments |
| Soggetto topico |
Cancer - Pathophysiology
Cancer cells Pathology, Cullular |
| ISBN | 1-5361-0837-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910164041903321 |
|
Poljsak Borut
|
||
| Hauppauge, NY : , : Nova Science Publishers, Incorporated, , [2017] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Cancer - Pathophysiology
(10)
- Cancer - Treatment (3)
- Neuropsychology (3)
- Symptoms (3)
- Cancer - Surgery (2)